The N.N. Blokhin National Medical Research Center of Oncology (NMRC) is completing preclinical trials of a personalized mRNA vaccine for the treatment of oncological diseases. This was announced by the Chief Visiting Specialist Oncologist of the Ministry of Health of Russia, Director of the Scientific Center Ivan Stilidi.
We are currently completing preclinical trials on animal models at the N.N. Blokhin NMRC of Oncology of the Ministry of Health of Russia, so it is too early to talk about specific dates. It is important to understand that a neoantigenic mRNA vaccine is not a panacea, like any other method in oncology.
Preclinical studies of the cancer vaccine have demonstrated its ability to suppress tumor development. As part of clinical trials, patients with intercellular lung cancer or melanoma will receive the drug.
Scientists plan to develop models of various oncological diseases to create personalized mRNA vaccines, including drugs against kidney, breast, and pancreatic cancer.
Earlier www1.ru reported that the cancer vaccine will be free for all Russians.
Read more on the topic:
Russian application for detecting skin cancer "ProRodinki" will be launched in polyclinics
Cancer defeated?: A revolutionary vaccine against all types of cancer has been developed in Russia
